丁丙诺啡、美沙酮及药物使用对COVID-19发病率和死亡率的影响

medRxiv - Addiction Medicine Pub Date : 2023-11-27 DOI:10.1101/2023.11.24.23298995

Nicholaus Christian, Xin Zhou, Rajiv Radhakrishnan

{"title":"丁丙诺啡、美沙酮及药物使用对COVID-19发病率和死亡率的影响","authors":"Nicholaus Christian, Xin Zhou, Rajiv Radhakrishnan","doi":"10.1101/2023.11.24.23298995","DOIUrl":null,"url":null,"abstract":"<strong>Objectives</strong> Substance use disorder has been associated with increased morbidity in COVID-19 infection. However, less is known about the impact of active substance use and medications for opioid use disorder (MOUD) on COVID-19 outcomes. We conducted a retrospective cohort study to evaluate the impact of substance use, namely cannabis, cocaine, alcohol, sedative and opioid use as well as buprenorphine or methadone = on COVID-19 morbidity and mortality.","PeriodicalId":501282,"journal":{"name":"medRxiv - Addiction Medicine","volume":"62 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality\",\"authors\":\"Nicholaus Christian, Xin Zhou, Rajiv Radhakrishnan\",\"doi\":\"10.1101/2023.11.24.23298995\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Objectives</strong> Substance use disorder has been associated with increased morbidity in COVID-19 infection. However, less is known about the impact of active substance use and medications for opioid use disorder (MOUD) on COVID-19 outcomes. We conducted a retrospective cohort study to evaluate the impact of substance use, namely cannabis, cocaine, alcohol, sedative and opioid use as well as buprenorphine or methadone = on COVID-19 morbidity and mortality.\",\"PeriodicalId\":501282,\"journal\":{\"name\":\"medRxiv - Addiction Medicine\",\"volume\":\"62 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Addiction Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2023.11.24.23298995\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Addiction Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2023.11.24.23298995","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

物质使用障碍与COVID-19感染的发病率增加有关。然而，人们对活性物质使用和阿片类药物使用障碍(mod)药物对COVID-19结局的影响知之甚少。我们进行了一项回顾性队列研究，以评估物质使用(即大麻、可卡因、酒精、镇静剂和阿片类药物使用以及丁丙诺啡或美沙酮)对COVID-19发病率和死亡率的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Effects of Buprenorphine, Methadone and Substance-Use on COVID-19 Morbidity and Mortality

Objectives Substance use disorder has been associated with increased morbidity in COVID-19 infection. However, less is known about the impact of active substance use and medications for opioid use disorder (MOUD) on COVID-19 outcomes. We conducted a retrospective cohort study to evaluate the impact of substance use, namely cannabis, cocaine, alcohol, sedative and opioid use as well as buprenorphine or methadone = on COVID-19 morbidity and mortality.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

medRxiv - Addiction Medicine

自引率

0.00%

发文量